Scorpius Holdings, Inc. (SCPX)
OTCMKTS · Delayed Price · Currency is USD
0.0011
0.00 (0.00%)
At close: Sep 4, 2026
Scorpius Holdings Market Cap
Scorpius Holdings has a market cap or net worth of $67.26 thousand as of September 4, 2026. Its market cap has decreased by -62.07% in one year.
Market Cap
67.26K
Enterprise Value
11.93M
Revenue
1.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since July 24, 2013, Scorpius Holdings's market cap has decreased from 58.15M to 67.26K, a decrease of -99.88%. That is a compound annual growth rate of -40.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 67.26K | 449.98% |
| Dec 31, 2025 | 12.23K | -99.24% |
| Dec 31, 2024 | 1.61M | -86.01% |
| Dec 29, 2023 | 11.48M | -44.42% |
| Dec 30, 2022 | 20.66M | -73.25% |
| Dec 31, 2021 | 77.23M | -36.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immunotech Laboratories | 114.99K |
| Synairgen | 110.27K |
| PaxMedica | 88.39K |
| ProtoKinetix | 82.33K |
| Sigyn Therapeutics | 73.75K |
| Vincerx Pharma | 68.57K |
| U.S. Stem Cell | 66.15K |
| Zenith Capital | 63.89K |